Universal Corporation (NYSE: UVV) — Form 10-Q Summary
Reporting period: Quarter and nine months ended December 31, 2023, corresponding to fiscal year 2024 Q3. The request metadata says “2022 Q3,” but the filing itself covers December 31, 2023.
Business context and performance
Universal is a global business-to-business supplier of leaf tobacco and plant-based ingredients. Results are seasonal, with tobacco working-capital needs typically peaking in the first half of the fiscal year. The company reports Tobacco Operations and Ingredients Operations.
| Metric | Quarter ended Dec. 31, 2023 | Year-to-date |
|---|---|---|
| Revenue | $821.5 million, up 3% year over year | $1,977.7 million, up 5% |
| Operating income | $87.5 million, up 13% | $153.8 million, up 20% |
| Net income attributable to Universal | $53.2 million, up 28% | $79.3 million, up 13% |
| Diluted EPS | $2.12, versus $1.67 | $3.17, versus $2.82 |
| Gross margin | 20.3%, versus 18.3% (calculated from reported revenue and cost of goods sold) | 19.5%, versus 17.9% |
Quarterly revenue growth reflected higher tobacco prices and favorable product mix, partly offset by lower tobacco volumes. Tobacco Operations generated $743.9 million of quarterly revenue and $87.6 million of segment operating income. Ingredients Operations generated $77.6 million of revenue and $2.2 million of segment operating income.
Cash flow, debt, and liquidity
- Operating cash flow: Cash used was $46.7 million for the nine months, compared with $183.9 million used in the prior-year period. Seasonal inventory purchases contributed to the outflow.
- Investing and financing: Capital expenditures were $47.7 million; net cash used in investing was $42.0 million. Financing provided $98.1 million, including $170.4 million of net short-term debt issuance. Cash increased by $9.4 million to $74.1 million.
- Debt and liquidity: At December 31, 2023, short-term debt and overdrafts were $365.3 million and long-term debt was $617.2 million. Net debt as a percentage of net capitalization was approximately 40%, versus 35% at March 31, 2023. The company reported $335 million available under its committed revolver and about $175 million of uncommitted credit lines, and said it was in compliance with debt covenants.
- Working capital: Tobacco inventory was $1.009 billion, up $175.2 million from March 31, 2023, reflecting seasonal purchases of larger crops. Management said seasonal working-capital needs had begun to contract by quarter-end.
- Shareholder returns: Quarterly dividends declared were $0.80 per share. No shares were repurchased during the quarter; $95.3 million remained available under the repurchase authorization.
Material changes and management commentary
- Tobacco Operations benefited from higher prices, favorable mix, strong shipments, and larger African crops; lower volumes partly offset these factors. Management cited tight global leaf supply and expected supply to remain tight in fiscal 2025, partly due to El Niño conditions.
- Ingredients Operations’ nine-month operating income fell to $5.0 million from $9.9 million. Management cited customer inventory recalibrations earlier in the year, lower raw-material prices, inventory write-downs, and higher investment-related expenses. New-product sales supported quarterly results.
- Interest expense rose to $48.1 million year to date from $33.3 million, primarily reflecting higher interest rates. The company had $310 million of interest-rate swaps outstanding. It estimated that a hypothetical 1% increase in short-term rates would raise annual interest expense by approximately $6.8 million, at least partly mitigated by customer charges.
- Restructuring and impairment costs were $3.5 million year to date, including work at the Global Labs Services facility and costs in other Tobacco Operations areas.
- Management expects $55–$65 million of capital spending over the next 12 months. Expanded processing capacity at its Lancaster, Pennsylvania, ingredients facility is expected to be fully operational in fiscal Q3 2025 and to contribute positively to earnings beginning as soon as fiscal 2026. No specific full-year earnings guidance is provided in the supplied filing text.
Risks, contingencies, and unusual items
- Brazil VAT disputes remain unresolved. The Santa Catarina assessment is approximately $11 million including accumulated interest, and the reduced Paraná assessment is approximately $3 million. Management considers no loss probable and recorded no liability; the possible loss range for each matter extends from zero to the remaining assessment. Resolution may take a lengthy period.
- Other litigation and tax matters are described as incidental to business. Management does not currently expect a material adverse effect on business or financial position, but an adverse resolution could materially affect a particular reporting period.
- Recoverable VAT credits totaled approximately $63 million gross with $21 million of valuation allowances. Supplier advances totaled $186 million, with $25 million of related valuation allowances.
- Management cited risks including customer concentration, supply and demand, shipment timing, inflation and transportation costs, weather, foreign exchange and interest rates, political and economic conditions, regulation, litigation, climate-related risks, and integration of acquisitions. The filing reported no material changes to the previously disclosed risk factors.
- Adjusted operating income and adjusted EPS are non-GAAP measures. Year-to-date adjusted diluted EPS was $3.29 versus reported EPS of $3.17; the filing’s adjustments include restructuring costs and prior-year Tanzania-sale-related items.
Important facts for investors to verify
- Confirm the intended reporting period: this filing covers fiscal 2024 Q3, not 2022 Q3.
- Track whether tight tobacco supply, crop conditions, shipment timing, and the low level of uncommitted inventory support margins and customer commitments.
- Monitor Ingredients Operations’ recovery, customer inventory levels, product mix, and returns from the planned capacity expansion.
- Assess seasonal cash conversion, inventory funding, short-term borrowing, interest-rate exposure, and available credit capacity.
- Follow developments in the Brazilian VAT disputes and the recoverability of VAT credits and supplier advances.